| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | PARATEK PHARMACEUTICALS INC | 1,301,413 | 19,703,000 | 18.31% | ||
| 2 | CHIASMA INC | 2,080,595 | 19,037,000 | 17.69% | ||
| 3 | Proteon Therapeutics | 2,017,872 | 15,558,000 | 14.46% | ||
| 4 | SIENTRA INC | 2,199,012 | 15,041,000 | 13.98% | ||
| 5 | CEMPRA INC | 383,935 | 6,723,000 | 6.25% | ||
| 6 | Dicerna Pharmaceuticals | 945,757 | 5,060,000 | 4.70% | ||
| 7 | TOBIRA THERAPEUTICS INC | 589,244 | 4,785,000 | 4.45% | ||
| 8 | Innocoll | 555,555 | 4,667,000 | 4.34% | ||
| 9 | LOMBARD MEDICAL INC | 3,473,452 | 3,751,000 | 3.49% | ||
| 10 | CELLECTIS S A | 100,000 | 2,735,000 | 2.54% | ||
| 11 | REGULUS THERAPEUTICS INC | 327,350 | 2,265,000 | 2.10% | ||
| 12 | CymaBay Therapeutics | 1,600,000 | 2,160,000 | 2.01% | ||
| 13 | ADAPTIMMUNE THERAPEUTICS PLC | 250,000 | 2,028,000 | 1.88% | ||
| 14 | ANTHERA PHARMACEUTICALS I | 437,994 | 1,577,000 | 1.47% | ||
| 15 | DERMIRA INC | 70,000 | 1,448,000 | 1.35% | ||
| 16 | CHEMOCENTRYX INC | 215,000 | 533,000 | 0.50% | ||
| 17 | OncoGenex Pharmaceuticals Inc | 396,104 | 271,000 | 0.25% | ||
| 18 | AURINIA PHARMACEUTICALS INC | 88,307 | 256,000 | 0.24% | ||
| 19 | EPIRUS BIOPHARMA | 7,896 | 21,000 | 0.02% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-16-017004, filed 2016.05.13).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
